Cargando…
Prognostic Factors for the Therapeutic Performance of Cisplatin in Head and Neck Malignancies
INTRODUCTION: For squamous cell carcinoma of the head and neck (HNSCC), cisplatin is used as primary or adjuvant (radio)chemotherapy. In terms of dosage, two main regimens are used, weekly 40mg/m(2) or 3-weekly 100mg/m(2). For an optimal outcome, the highest possible cumulative total dose of cisplat...
Autores principales: | Jungbauer, Frederic, Huber, Lena, Ludwig, Sonja, Rotter, Nicole, Walter, Beatrice, Zaubitzer, Lena, Lammert, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096481/ https://www.ncbi.nlm.nih.gov/pubmed/35574347 http://dx.doi.org/10.3389/fonc.2022.778380 |
Ejemplares similares
-
Prevalence of subjective impairments of the sense of smell and taste in employees of retirement and nursing homes during SARS‐CoV‐2 pandemic
por: Jungbauer, Frederic, et al.
Publicado: (2021) -
Professionelle Teamarbeit und Kommunikation im Operationssaal – Eine narrative Übersicht
por: Lammert, Anne, et al.
Publicado: (2021) -
Metastasis of pulmonary adenocarcinoma to the palatine tonsil
por: Zaubitzer, Lena, et al.
Publicado: (2019) -
The effects of COVID-19 on the vestibular system
por: Zaubitzer, Lena, et al.
Publicado: (2023) -
Post-COVID-19 Impairment of the Senses of Smell, Taste, Hearing, and Balance
por: Ludwig, Sonja, et al.
Publicado: (2022)